Reid Merryman, MD
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Epco, Zanu, Ritux for R/R FL or MZL (NCT06563596) | Reid Merryman, MD | 2025-01-21 |
| Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma (NCT05783596) | Reid Merryman, MD | 2023-07-18 |
| Epcoritamab and Rituximab for First-line Follicular Lymphoma (NCT05783609) | Reid Merryman, MD | 2023-06-21 |
Track Reid Merryman, MD automatically
Every clearance here is in the API, with alerts when new ones post.